Status:
COMPLETED
The Effect of Peppermint Oil on Nausea, Vomiting and Retching in Cancer Patients Undergoing Chemotherapy
Lead Sponsor:
TC Erciyes University
Conditions:
Chemotherapy Effect
Adverse Effect
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study was to determine the effect of peppermint oil upon incidence of nausea, vomiting and retching, nause severity, and the usage amount of antiemetics in cancer patients undergoing c...
Detailed Description
Nausea, vomiting and retching symptoms are among the most common adverse effects of chemotherapy and are defined with expressions like "the biggest problem including pain" by patients. Chemotherapy-in...
Eligibility Criteria
Inclusion
- Patients who
- were aged ≥18 years,
- were able to understand Turkish language and to communicate in Turkish language,
- had cancer diagnosis,
- received chemotherapy treatment for -at least- the second time with similar chemotherapeutic agents,
- experienced nausea symptoms according to VAS
- were not pregnant and not intending pregnancy,
- had -at most- stage III cancer
- presented no psychiatric disorders,
- were not included in pre-implementation phase of the study were accepted to the study.
Exclusion
- Patients who
- suffered from another disease that may affect nausea vomiting status,
- were allergic to or disturbed by smell of peppermint,
- were newly diagnosed, and receiving chemotherapy for the first time,
- received concomitant radiotherapy,
- received other complementary and integrative health practices during the treatment were not accepted to the study
Key Trial Info
Start Date :
September 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2018
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04118322
Start Date
September 10 2017
End Date
September 10 2018
Last Update
October 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuriye EFE ERTURK
Batman, Central, Turkey (Türkiye)